SEMBER MICHAEL T has filed 4 insider transactions across 1 company since October 2023.
Most recent transaction: a grant/award of 8141 shares of Quoin Pharmaceuticals, Ltd. ($QNRX) on February 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Quoin Pharmaceuticals, Ltd. | $QNRX | SEMBER MICHAEL T | Director | A | Share Option (Right to Buy) | 8141 | $0.00 | 8,141.0000 | 1,584,905,594 | 9999.99% | 0.00% |
| May 29, 2025 | Quoin Pharmaceuticals, Ltd. | $QNRX | SEMBER MICHAEL T | Director | A | Share Option (Right to Buy) | 7760 | $0.00 | 7,760.0000 | 1,584,905,594 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | SEMBER MICHAEL T | Director | A | Share Option (Right to Buy) | 50714 | $0.00 | 50,714.0000 | 1,584,905,594 | 9999.99% | 0.00% |
| Oct. 26, 2023 | Quoin Pharmaceuticals, Ltd. | $QNRX | SEMBER MICHAEL T | Director | A | Share Option (Right to Buy) | 7652 | $0.00 | 7,652.0000 | 1,584,905,594 | 9999.99% | 0.00% |